1887

Abstract

We have studied human immunodeficiency virus type 1 (HIV-1) infection in human SH-SY5Y neuroblastoma cells at various stages of morphological differentiation. Two days’ treatment of the cells with retinoic acid (RA) or dibutyryl cAMP (db-cAMP) resulted in the appearance of elongated neurites and enhanced production of 160K to 200K neurofilament proteins as shown by indirect immunofluorescence. DNA synthesis was reduced only in RA-treated cells as detected by 5-bromo- 2-deoxyuridine incorporation. The cells were infected with two T-lymphotropic virus strains (IIIB and NDK) and two fresh isolates (39001 and 46001) from bron- choalveolar lavage samples of AIDS patients. The latter two isolates were unable to form syncytia in infected CD4-positive T-lymphoblastoid C8166 cells which was in contrast to our T-lymphotropic virus strains. Interphase hybridization showed that 14 to 16 % of SH- SY5Y cells become positive for HIV-1 DNA. Regardless of the virus strain, morphological differentiation of the cells with RA or db-cAMP inhibited infection by 50 % at a single cell resolution. Nested PCR confirmed the presence of proviral DNA in the infected cells. These results show that human neuroblastoma cells, tumour cells of neuroectodermal origin, can be infected by different HIV-1 isolates and that the infection is inhibited by neurotypic cell differentiation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-1-201
1994-01-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/1/JV0750010201.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-1-201&mimeType=html&fmt=ahah

References

  1. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R., Pert C. B. 1988; Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature; London: 335639–642
    [Google Scholar]
  2. Cheng-Mayer C., Weiss C., Seto D., Levy J. A. 1989; Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proceedings of the National Academy of Sciences. U.S.A 86:8575–8579
    [Google Scholar]
  3. Chiodi F., Fuerstenberg S., Gidlund M., Åsjö B., Fenyö E. M. 1987; Infection of brain-derived cells with the human immunodeficiency virus. Journal of Virology 61:1244–1247
    [Google Scholar]
  4. Everall I. P., Luthert P. J., Lantos P. L. 1991; Neuronal loss in the frontal cortex in HIV infection. Lancet 337:1119–1121
    [Google Scholar]
  5. Harouse J. M., Bhat S., Spitalnik S. L., Laughlin M., Stefano K., Silberberg D. H., Gonzales-Scarano F. 1991; Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosylceramide. Science 253:320–323
    [Google Scholar]
  6. Keys B., Albert J., Kövamees J., Chiodi F. 1991; Brain-derived cells can be infected with HIV isolates derived from blood and brain. Virology 183:834–839
    [Google Scholar]
  7. Koyanagi Y., Miles S., Mitsuyasu R. T., Merril J. E., Vinters H. V., Chen I. S. Y. 1987; Dual infection of the central nervous system by AIDS viruses with distinct cellular tropism. Science 236:819–822
    [Google Scholar]
  8. Kunsch C., Hartle H. T., Wigdahl B. 1989; Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope. Journal of Virology 63:5054–5061
    [Google Scholar]
  9. Lee M. R., Ho D. D., Gurney M. R. 1987; Functional interaction and partial homology between human immunodeficiency virus and neuroleukin. Science 237:1047–1051
    [Google Scholar]
  10. Li X. L., Moudgil T., Vinters H. V., Ho D. D. 1990; CD-4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. Journal of Virology 64:1383–1387
    [Google Scholar]
  11. Merril J. E. 1991; The effect of IL1 and TNF alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Developmental Neuroscience 13:130–137
    [Google Scholar]
  12. Merril J. E., Chen I. S. Y. 1991; HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB Journal 5:2391–2397
    [Google Scholar]
  13. Navia B. A., Jordan B. D., Price R. W. 1986; The AIDS dementia complex. I. Clinical features. Annals of Neurology 19:517–524
    [Google Scholar]
  14. Neuman T., Stephens R. W., Salonen E.-M., Timmusk T., Vaheri A. 1989; Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue-type plasminogen activator. Journal of Neuroscience Research 23:274–281
    [Google Scholar]
  15. O’Brien W. A., Koyanagi Y., Namazie A., Zhao J.-Q., Diagne A., Idler K., Zack J. A., Chen I. S. Y. 1990; HIV-1 tropism for mononuclear phagocytes can be determined by regions of gpl20 outside the CD4-binding domain. Nature; London: 34869–73
    [Google Scholar]
  16. Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C., Cleary P. 1988; The brain in AIDS: central nervous system HIV- 1 infection and AIDS dementia complex. Science 239:586–592
    [Google Scholar]
  17. Robbins D. S., Shirazi Y., Drysdale B.-E., Lieberman A., Shin H. S., Shin M. L. 1987; Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. Journal of Immunology 139:2593–2597
    [Google Scholar]
  18. Selmaj K. W., Raine C. S. 1988; Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Annals of Neurology 23:339–346
    [Google Scholar]
  19. Sharpless N. E., O’Brien W. A., Verdin E., Kufta C. V., Chen I. S. Y., Dubois-Dalcq M. 1992a; Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. Journal of Virology 66:2588–2593
    [Google Scholar]
  20. Sharpless N., Gilbert D., Vandercam B., Zhou J. M., Verdin E., Ronnett G., Friedman E., Dubois-Dalcq M. 1992b; The restricted nature of HIV-1 tropism for cultured neural cells. Virology 191:813–825
    [Google Scholar]
  21. Vesanen M., Linna T., Vaheri A. 1991; Persistent inapparent HIV-1 infection of human neuroblastoma cells. Archives of Virology 120:253–261
    [Google Scholar]
  22. Vesanen M., Wessman M., Salminen M., Vaheri A. 1992; Activation of integrated human immunodeficiency virus type 1 in humanneuroblastoma cells by the cytokines tumour necrosis factor alpha and interleukin-6. Journal of General Virology 73:1753–1760
    [Google Scholar]
  23. Wigdahl B., Kunsch C. 1990; Human immunodeficiency virus infection and neurologic dysfunction. Progress in Medical Virology 37:1–46
    [Google Scholar]
  24. Yahi N., Baghdiguian S., Moreau H., Fantini J. 1992; Galactosylceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. Journal of Virology 66:4848–4854
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-1-201
Loading
/content/journal/jgv/10.1099/0022-1317-75-1-201
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error